Back to top
more

GENEDX HOLDINGS (WGS)

(Real Time Quote from BATS)

$125.45 USD

125.45
145,962

+4.08 (3.36%)

Updated Sep 17, 2025 12:06 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value A Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 41% (100 out of 245)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Zacks.com featured highlights include Snap, GeneDx and Leonardo

by Zacks Equity Research

Snap, GeneDx and Leonardo are part of the Zacks screen of the Week article.

Zacks Equity Research

Zacks.com featured highlights include Snap, GeneDx and Leonardo

by Zacks Equity Research

Snap, GeneDx and Leonardo are part of the Zacks Screen of the Week article.

Tirthankar Chakraborty headshot

3 Stocks to Buy for Stellar Earnings Acceleration in November

by Tirthankar Chakraborty

Stocks like Snap, GeneDx Holdings and Leonardo DRS exhibit solid earnings acceleration.

Zacks Equity Research

Best Momentum Stocks to Buy for November 4th

by Zacks Equity Research

WGS, CVNA and NBBK made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 4, 2024.

Zacks Equity Research

New Strong Buy Stocks for November 4th

by Zacks Equity Research

CFFN, VLRS, NBBK, WGS and ISBA have been added to the Zacks Rank #1 (Strong Buy) List on November 4, 2024.

Zacks Equity Research

GeneDx Holdings Corp. (WGS) Tops Q3 Earnings and Revenue Estimates

by Zacks Equity Research

GENEDX HOLDINGS (WGS) delivered earnings and revenue surprises of 121.05% and 18.27%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Best Momentum Stocks to Buy for August 5th

by Zacks Equity Research

WGS, MCY and MHO made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 5, 2024.

Zacks Equity Research

How Much Upside is Left in GENEDX HOLDINGS (WGS)? Wall Street Analysts Think 40.34%

by Zacks Equity Research

The consensus price target hints at a 40.3% upside potential for GENEDX HOLDINGS (WGS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Zacks Equity Research

New Strong Buy Stocks for August 5th

by Zacks Equity Research

KGC, MCY, WGS, CHRW and FULC have been added to the Zacks Rank #1 (Strong Buy) List on August 5, 2023.

Zacks Equity Research

GeneDx Holdings Corp. (WGS) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

GENEDX HOLDINGS (WGS) delivered earnings and revenue surprises of 57.69% and 19.72%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Best Momentum Stocks to Buy for July 23rd

by Zacks Equity Research

WGS, THC and APOG made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 23, 2024.

Zacks Equity Research

New Strong Buy Stocks for July 23rd

by Zacks Equity Research

KRO, TEF, STX, WGS and THC have been added to the Zacks Rank #1 (Strong Buy) List on July 23, 2024.

Zacks Equity Research

What Makes GeneDx Holdings Corp. (WGS) a Strong Momentum Stock: Buy Now?

by Zacks Equity Research

Does GeneDx Holdings Corp. (WGS) have what it takes to be a top stock pick for momentum investors? Let's find out.

Nalak Das headshot

Small Caps Climb on Interest Rate Cut Expectations: 5 Picks

by Nalak Das

We have narrowed our search to five small-cap stocks. These stocks are: AXL, NVRI, GRPN, BJRI, WGS.

Zacks Equity Research

Zacks.com featured highlights include Daktronics, Hess, Advanced Drainage Systems, Apogee and GENEDX

by Zacks Equity Research

Daktronics, Hess, Advanced Drainage Systems, Apogee and GENEDX have been highlighted in this Screen of The Week article.

Zacks Equity Research

All You Need to Know About GENEDX HOLDINGS (WGS) Rating Upgrade to Strong Buy

by Zacks Equity Research

GENEDX HOLDINGS (WGS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Santanu Roy headshot

5 Must-Buy Efficient Stocks to Enrich Your Portfolio

by Santanu Roy

Invest in companies like Daktronics (DAKT), Hess (HES), Advanced Drainage Systems (WMS), Apogee Enterprises (APOG) and GENEDX HOLDINGS (WGS) to make the most of higher efficiency levels.

Zacks Equity Research

GeneDx Holdings Corp. (WGS) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

GENEDX HOLDINGS (WGS) delivered earnings and revenue surprises of 51.47% and 25.35%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Abhinab Dasgupta headshot

Take the Zacks Approach to Beat the Market: Virtu, Coinbase, General Mills in Focus

by Abhinab Dasgupta

Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.

Zacks Equity Research

Here's Why GENEDX HOLDINGS (WGS) Could be Great Choice for a Bottom Fisher

by Zacks Equity Research

GENEDX HOLDINGS (WGS) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Zacks Equity Research

Bears are Losing Control Over GeneDx Holdings Corp. (WGS), Here's Why It's a 'Buy' Now

by Zacks Equity Research

After losing some value lately, a hammer chart pattern has been formed for GeneDx Holdings Corp. (WGS), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Zacks Equity Research

PacBio (PACB) Inks Research Collaboration for Genome Sequencing

by Zacks Equity Research

PacBio (PACB) and GeneDx sign a deal with the University of Washington to study long-read sequencing in rare diseases. The study will use PacBio's Revio system to explore novel variants.

Zacks Equity Research

Brookdale (BKD) May 2023 Occupancy Rises: Better Days Ahead?

by Zacks Equity Research

Brookdale (BKD) has witnessed 19 straight months of year-over-year increases in weighted average occupancy level.

Zacks Equity Research

Humana (HUM) Arm Reaches 250 Senior Primary Care Facilities

by Zacks Equity Research

Humana's (HUM) CenterWell business focuses on providing a better healthcare experience through clubbing primary care, home health and pharmacy services.

Zacks Equity Research

Should You Retain Acadia Healthcare (ACHC) in Your Portfolio?

by Zacks Equity Research

Acadia Healthcare's (ACHC) top line is likely to receive support from growth in specialty treatment and acute inpatient psychiatric facilities.